A task force of 15 physicians and healthcare professionals proposed a ban on doctors giving promotional talks for drug companies and are recommending that doctors disclose monies received from drug or medical device companies within $1,000.
Read the Journal Sentinel’s report on UW’s new conflict-of-interest rules.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.